(19)
(11) EP 4 551 603 A1

(12)

(43) Date of publication:
14.05.2025 Bulletin 2025/20

(21) Application number: 23742383.5

(22) Date of filing: 05.07.2023
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C12N 5/0783(2010.01)
C07K 14/725(2006.01)
A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2851; C07K 16/2866; C07K 16/2854; C07K 2317/622; C07K 2317/22; C07K 2317/31; C07K 2319/33; C07K 2319/03; A61K 2039/5156; C07K 14/7051; C12N 2510/00; C07K 14/70578; A61K 2239/10; A61K 2239/29; A61P 35/02; A61K 2239/48; A61K 40/421; A61K 40/4219; A61K 40/4254; A61K 40/31; A61K 40/11
(86) International application number:
PCT/GB2023/051774
(87) International publication number:
WO 2024/009093 (11.01.2024 Gazette 2024/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 06.07.2022 GB 202209920

(71) Applicant: Autolus Limited
London W12 7FP (GB)

(72) Inventors:
  • GHORASHIAN, Sara
    London W12 7FP (GB)
  • HAZELTON, Warren
    London W12 7FP (GB)

(74) Representative: D Young & Co LLP 
3 Noble Street
London EC2V 7BQ
London EC2V 7BQ (GB)

   


(54) ENGINEERED TRISPECIFIC TANCAR EXPRESSING CELLS TARGETING CD33, CD123 AND CLL1 AND USES THEREOF IN CANCER THERAPY